Case-By-Case Guide As Justices Eye Landmark Pharma Law
By Jeff Overley · April 4, 2026, 12:04 AM EDT
Already a subscriber? Click here to login
Analysis
By Jeff Overley · April 4, 2026, 12:04 AM EDT
Already a subscriber? Click here to login
MERCK & CO., INC. v. BECERRA et al
District Of Columbia
Civil Rights: Other
June 06, 2023
AstraZeneca Pharmaceuticals LP, et al v. Secretary United States Department of Health and H, et al
Appellate - 3rd Circuit
2899 APA Review/Appeal
May 02, 2024
Bristol Myers Squibb Co v. Secretary United States Department of HHS, et al
Appellate - 3rd Circuit
2440 Other Civil Rights
May 06, 2024
Janssen Pharmaceuticals Inc v. Secretary United States Department of HHS, et al
Appellate - 3rd Circuit
2440 Other Civil Rights
May 06, 2024
Boehringer Ingelheim Pharmaceuticals, Inc. v. United States Department of Health and Human Services
Appellate - 2nd Circuit
August 08, 2024
Novo Nordisk Inc, et al v. Secretary US Dept & Health and Human Services, et al
Appellate - 3rd Circuit
2899 APA Review/Appeal
August 19, 2024
Novartis Pharmaceuticals Corp v. Secretary United States Department of Health, et al
Appellate - 3rd Circuit
2440 Other Civil Rights
October 22, 2024
Natl Infusion Center v. Kennedy
Appellate - 5th Circuit
2440 Other Civil Rights
August 15, 2025
AstraZeneca Pharmaceuticals LP, et al., Petitioners v. Robert F. Kennedy, Secretary of Health and Human Services, et al.
Supreme Court
2899 APA Review/Appeal
September 24, 2025
Janssen Pharmaceuticals, Inc., Petitioner v. Robert F. Kennedy, Secretary of Health and Human Services, et al.
Supreme Court
2440 Other Civil Rights
December 23, 2025
Bristol Myers Squibb Company, Petitioner v. Robert F. Kennedy, Secretary of Health and Human Services, et al.
Supreme Court
2440 Other Civil Rights
December 23, 2025
Novo Nordisk Inc., et al., Petitioners v. Robert F. Kennedy, Secretary of Health and Human Services, et al.
Supreme Court
2899 APA Review/Appeal
December 29, 2025
Boehringer Ingelheim Pharmaceuticals, Inc., Petitioner v. Department of Health and Human Services, et al.
Supreme Court
January 07, 2026
Novartis Pharmaceuticals Corporation, Petitioner v. Robert F. Kennedy, Secretary of Health and Human Services, et al.
Supreme Court
2440 Other Civil Rights
February 02, 2026
March 18, 2026
Key Details As 3rd Circ. Ponders FCA's Fate, $1.6B J&J FineMarch 17, 2026
9th Circ. Backs Rare FCA Theory In Huge Drug Prices ProgramMarch 13, 2026
'Swinging Dicks' Dissent Stirs Uproar Across 9th Circ. BenchFebruary 06, 2026
'Very Bizarre': Trump's Funding Freeze Appeal Vexes DC Circ.January 20, 2026
Justices Ax 6th Circ. Abortion Order Amid Loper Bright OutcryJanuary 12, 2026
The Curious, Very Long Delay In A Pioneering Drug Prices SuitAugust 27, 2025
DOJ Throws Lifeline To J&J At 3rd Circ. After $1.6B FCA LossAugust 12, 2025
Loper Bright Neutered In 6th Circ., Tenn. Tells Supreme CourtAugust 06, 2025
6th Circ. Rips 'Stalking Horse' Ploy In Drug Negotiation SuitAugust 05, 2025
Key Opioid Theory Actually Irrelevant, Drug Cos. Tell 4th Circ.